Modi Naturals Investor Presentation Nov'26: H1FY27 Revenue Up 19.3% to ₹361.9 Cr
Modi Naturals' H1 FY27 consolidated revenue grew 19.3% to ₹361.9 Cr, with EBITDA up 25.1% to ₹40.8 Cr. PAT increased 14.4% to ₹23.5 Cr. The company secured ethanol orders worth ₹495 Cr. Despite Q2 margin pressure from raw material costs, normalization is expected.
The announcement provides a detailed financial update and outlook, including growth figures and strategic initiatives. While the growth is positive, the impact is considered medium as it's an investor presentation and not a direct financial results release with immediate market-moving news.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT for H1 FY27. Despite short-term margin pressures in Q2 due to raw material costs, the outlook is positive with expected normalization and strong order visibility in the ethanol division.
Modi Naturals Limited has released its Investor Presentation for November 2026, detailing its financial performance for Q2 and H1 FY27.
For H1 FY27, the company reported a consolidated revenue from operations growth of 19.3% to ₹361.9 crores. EBITDA increased by 25.1% to ₹40.8 crores, with EBITDA margins improving to 11.3% from 10.7% in H1 FY26. Profit After Tax (PAT) also saw a growth of 14.4% to ₹23.5 crores.
The company experienced pressure on profitability in Q2 FY27 due to a sharp increase in raw material prices, particularly for edible oil and grains. However, input prices have started normalizing, which is expected to ease cost pressures in the coming quarters.
The Consumer Division continues to focus on premiumization, product mix improvement, and distribution expansion. The association with Karisma Kapoor as Oleev's brand ambassador has been extended. New products in snacking and high-protein categories are planned.
Modi Biotech, a wholly-owned subsidiary, has secured orders worth approximately ₹495 crore for about 7.82 crore litres of ethanol for the upcoming Ethanol Supply Year (ESY), providing good revenue visibility.
The Bulk Division's revenue growth in Q2 FY27 was driven by higher realisations due to increased commodity prices. As prices correct, realisations are expected to moderate.
Looking ahead, the company is confident in achieving its FY27 guidance, supported by the ramp-up of the Ethanol Division, strengthening of the Consumer business, and an improving raw material price environment.
What to do with a filing like this
Modi Naturals Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Modi Naturals Limited. Read the original for the full detail.